|
|
Trans Genic Inc - Comparative Business Analysis Snapshot
Business Description
Trans Genic Inc. The Group's principal activities are to manufacture, develop, sell and provide bio- venture business producing mice (knockout mouse) with gene disruption and sell genetic information to pharmaceutical firms. It is also involved in operating distribution business and outsourcing business. The operations are carried out through the following divisions: Gene knockout mouse business; Antibody business; Testing drug sale and Others. The Gene knockout mouse business deals with gene information income from consigned production. The Antibody business division includes antibody income from consigned production.
Competitor Analysis
This analysis compares Trans Genic Inc with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
